STANDARD BIOTOOLS INC. - COMMON STOCK

Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging

08 апр 2024 08:00:00 Источник Nasdaq GlobeNewswire

Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research

03 апр 2024 16:01:13 Источник Nasdaq GlobeNewswire

Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock

18 мар 2024 08:12:23 Источник Nasdaq GlobeNewswire

Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results

28 фев 2024 16:01:00 Источник Nasdaq GlobeNewswire

Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing

26 фев 2024 08:00:00 Источник Nasdaq GlobeNewswire

Standard BioTools to Participate in Upcoming Investor Conferences

22 фев 2024 16:05:00 Источник Nasdaq GlobeNewswire

Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

14 фев 2024 08:30:00 Источник Nasdaq GlobeNewswire

Standard BioTools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized Medicine

07 фев 2024 08:30:35 Источник Nasdaq GlobeNewswire

Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 Revenue

08 янв 2024 08:30:32 Источник Nasdaq GlobeNewswire

Standard BioTools Completes Merger with SomaLogic, Creating a Diversified and Scaled Leader in Life Sciences Tools

05 янв 2024 08:46:55 Источник Nasdaq GlobeNewswire

Standard BioTools Stockholders Approve Merger with SomaLogic

04 янв 2024 22:23:06 Источник Nasdaq GlobeNewswire

Glass Lewis Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic

29 дек 2023 17:04:12 Источник Nasdaq GlobeNewswire

ISS Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic

22 дек 2023 18:57:33 Источник Nasdaq GlobeNewswire

Standard BioTools and SomaLogic Announce Date for Special Meetings of Stockholders to Vote on Proposed Merger

04 дек 2023 08:00:01 Источник Nasdaq GlobeNewswire

Standard BioTools Reports Third Quarter and Year-to-Date 2023 Financial Results

07 ноя 2023 16:00:08 Источник Nasdaq GlobeNewswire

Standard BioTools to Present at the Jefferies London Healthcare Conference

02 ноя 2023 08:30:33 Источник Nasdaq GlobeNewswire

Standard BioTools Announces Conference Call and Webcast of Third Quarter 2023 Financial Results on November 7, 2023

25 окт 2023 08:30:24 Источник Nasdaq GlobeNewswire

Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools

04 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire

Standard BioTools Reports Second Quarter 2023 Financial Results

08 авг 2023 16:05:36 Источник Nasdaq GlobeNewswire

Standard BioTools to Participate in Upcoming Investor Conferences

26 июл 2023 16:05:06 Источник Nasdaq GlobeNewswire